Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Return on Sales: 2020-2021

  • Genmab A's Return on Sales fell 13.00% to 0.00% in Q2 2021 from the same period last year, while for Jun 2021 it was 0.00%, marking a year-over-year decrease of 13.00%. This contributed to the annual value of 0.47% for FY2020, which is 7.00% up from last year.
  • Latest data reveals that Genmab A reported Return on Sales of 0.00% as of Q2 2021, which was up 100.00% from -0.27% recorded in Q4 2020.
  • In the past 5 years, Genmab A's Return on Sales registered a high of 0.13% during Q2 2020, and its lowest value of -0.27% during Q4 2020.
  • Over the past 2 years, Genmab A's median Return on Sales value was 0.00% (recorded in 2021), while the average stood at -0.05%.
  • Data for Genmab A's Return on Sales shows a maximum YoY dropped of 13bps (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Genmab A's Return on Sales stood at -0.27% in 2020, then declined by 13bps to 0.00% in 2021.
  • Its last three reported values are 0.00% in Q2 2021, -0.27% for Q4 2020, and 0.13% during Q2 2020.